Description
TO PROCURE DNA,RNA AND PROTEIN LYSATE SAMPLES OF PATIENTS NECESSARY FOR PROJECT: DNA IS USED TO DETERMINE POLYMORPHIC STATUS OF PATIENTS
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-08-29+$13,327= $13,327
- Mod 12012-02-07+$481= $13,807
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-08-29 | +$13,327 | $13,327 | TO PROCURE DNA,RNA AND PROTEIN LYSATE SAMPLES OF PATIENTS NECESSARY FOR PROJECT: DNA IS USED TO DETERMINE POLY… |
| Mod 1· FUNDING ONLY ACTION | 2012-02-07 | +$481 | $13,807 | TO PROCURE DNA,RNA AND PROTEIN LYSATE SAMPLES OF PATIENTS NECESSARY FOR PROJECT: DNA IS USED TO DETERMINE POLY… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI J6D6NR41SF54)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24E23P0098 | RPO EAST (36C24E) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $76,045 | FY2023 |
| 36C24223P0943 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · AJ11 · GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH | $27,407 | FY2023 |
| VA24115P2024 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6810 · CHEMICALS | $0 | FY2015 |
| VA25112P1002 | 553-DETROIT · 6505 · DRUGS AND BIOLOGICALS | $6,000 | FY2012 |
| VA603D10022 | 249-NETWORK CONTRACT OFFICE 9 · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $9,168 | FY2011 |
| VA662D10234 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $11,040 | FY2011 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26116F1413 | CSL BEHRING L.L.C. | 261-NETWORK CONTRACT OFFICE 21 | $12,789 | FY2016 |
| VA26116F1408 | CSL BEHRING L.L.C. | 261-NETWORK CONTRACT OFFICE 21 | $10,733 | FY2016 |
| VA26116F1244 | SEQIRUS USA INC | 261-NETWORK CONTRACT OFFICE 21 | $31,450 | FY2016 |
| VA26116F1240 | SEQIRUS USA INC | 261-NETWORK CONTRACT OFFICE 21 | $7,234 | FY2016 |
| VA26116F1213 | SEQIRUS USA INC | 261-NETWORK CONTRACT OFFICE 21 | $62,900 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA662D10233_3600_-NONE-_-NONE- · retrieved 2026-09-26.